Skip to main content
Log in

Bioequivalence studies in humans of indomethacin capsules marketed in India

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Two, separate 6×6 Latin square cross-over bioequivalence studies were performed in adult male volunteers using 10 different indomethacin capsule preparations marketed in India together with the pure drug powder as the standard. The products were evaluated with respect to plasma level at various times up to 8 h following administration of a 50 mg (2 × 25 mg) dose. Plasma samples were analysed by a fluorimetric method. Various pharmacokinetic parameters were calculated according to a two compartment model. Statistical evaluation of the data employed analysis of variance for a cross-over design (ANOVA) and Duncan's multiple range test to ascertain the significance of differences between the products. Of the 10 products studied, two were found to be bioinequivalent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dipalma JR (1976) Basic pharmacology in medicine, McGraw-Hill, New York, p 147

    Google Scholar 

  2. Chodos DJ, DiSanto AR (1979) Basics of bioavailability. c.f. Blanchard J, Sawchuk RJ, Brodie BB (eds). In: Principles and perspectives in drug bioavailability, Karger, Basel, p 282

    Google Scholar 

  3. Stein G (1977) Pharmacokinetics of indomethacin and metabolites of indomethacin after repeated administration to patients with normal and abnormal renal function. Int J Clin Pharmacol Biopharm 15: 470

    Google Scholar 

  4. Alvan GC, Orme M, Bertilsson L, Eustrand R, Palmer L (1975) Pharmacokinetics of indomethacin. Clin Pharmacol Ther 18: 364

    Google Scholar 

  5. Hucker HB, Zacchei AG, Cox SV, Brodie DA, Cantwell NHR (1963) Studies on the absorption, distribution and excretion of indomethacin in various species, J Pharmacol Exp Ther 153 [2]: 237

    Google Scholar 

  6. Kwan KC, Breault GO, Umbenhauer ER, McMohan FG, Duggan DE (1976) Kinetics of indomethacin absorption, elimination and enterohepatic circulation in man. J Pharmacokinet Biopharm 4 [3]: 255

    Google Scholar 

  7. Rowe JS, Carless JE (1981) Comparison of the in vitro dissolution behaviour of various indomethacin formulations with their in vivo bioavailability. J Pharm Pharmacol 33: 561

    Google Scholar 

  8. Lindquist B, Jensen KM, Johansson H, Hansen T (1974) Effect of concurrent administration of aspirin and indomethacin on serum concentration. Clin Pharmacol Ther 15 [3]: 247

    Google Scholar 

  9. Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel. Dekker, New York, p 288

    Google Scholar 

  10. Duggan DE, Hooke KF, Noll RM, Kwan KC (1975) Enterohepatic circulation of indomethacin and its role in intestinal irritation, Biochem Pharmacol, 25: 1749

    Google Scholar 

  11. Anon (1977) Bioequivalence requirements and in vivo bioavailability procedures. Federal Register 7

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaudhari, G.N., Tipnis, H.P., Doshi, B.S. et al. Bioequivalence studies in humans of indomethacin capsules marketed in India. Eur J Clin Pharmacol 26, 261–264 (1984). https://doi.org/10.1007/BF00630296

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00630296

Key words

Navigation